Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocksWINDLAS
resources
WINDLAS

Windlas Biotech Ltd.

NSE: WINDLAS
BSE: 543329
Sector: Healthcare
Industry: Pharmaceuticals
872.70-31.7 (-3.51%)
23 Oct, 12:00 AM

Annual Reports and Financial Documents

Windlas Biotech Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

Corporate Announcements and Regulatory Filings

Windlas Biotech Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  1. Change in Management13 Oct 2026
    Announcement under Regulation 30 (LODR)-Change in Management
    Resignation of Mr. Vivek Dhariwal (DIN: 02826679), Independent Director of the Company, with effect from close of business hours on October 12, 2026
  2. Change in Management12 Oct 2026
    Announcement under Regulation 30 (LODR)-Change in Management
    Intimation of change in the composition of the Board in terms of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
  3. General12 Oct 2026
    Intimation Of Change In The Composition Of The Board In Terms Of Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
    Appointment and Resignation of Directors
  4. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20187 Oct 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Certificate under Regulation 74 (5) of the SEBl (Depositories and Participants) Regulations, 2018 for the Quarter ended September 30, 2026
  5. Closure of Trading Window25 Sept 2026
    Closure of Trading Window
    Intimation of Closure of Trading Window
  6. Analyst / Investor Meet1 Sept 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015
  7. General11 Aug 2026
    Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Recording Of Conference Call
    Audio Recording Q1 conference call
  8. Press Release / Media Release10 Aug 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Press release titled 'Windlas Biotech Limited Reports its Q1 FY27 Financial Results'
  9. Outcome of Board Meeting10 Aug 2026
    Board Meeting Outcome for Outcome Of The Board Meeting Held On August 10, 2026
    approval of the Unaudited Standalone Financial Results for the Quarter ended June 30, 2026.
  10. Analyst / Investor Meet5 Aug 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Schedule of Conference Call to discuss financial performance for quarter ended June 30, 2026
  11. Analyst / Investor Meet5 Aug 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Schedule of Conference Call to discuss financial performance for quarter ended June 30, 2026
  12. Board Meeting4 Aug 2026
    Board Meeting Intimation for Notice Of The Board Meeting Scheduled To Be Held On Monday, August 10, 2026
    Windlas Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 ,inter alia, to consider and approve Notice is hereby given that ....
  13. AGM24 Jul 2026
    Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
    Submission of Combined Voting Results and Scrutinizer's Report under Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') ....
  14. AGM24 Jul 2026
    Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
    Submission of Combined Voting Results and Scrutinizer's Report under Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') ....
  15. AGM23 Jul 2026
    Shareholder Meeting / Postal Ballot-Outcome of AGM
    Proceedings of 25th Annual General Meeting of the Company held on July 23, 2026, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
  16. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201810 Jul 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Certificate under Regulation 74 (5) of the SEBl (Depositories and Participants) Regulations, 2018 for the Quarter ended June 30, 2026
  17. Analyst / Investor Meet9 Jul 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015
  18. Newspaper Publication2 Jul 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper Advertisement of completion of despatch of the Notice of 25th Annual General Meeting and Annual Report for the financial year 2025-2026
  19. General1 Jul 2026
    Intimation Of Record Date/ Cut-Off Date For The 25Th AGM And Evoting
    Intimation of record date/ cut-off date for the 25th AGM and evoting
  20. Reg. 34 (1) Annual Report1 Jul 2026
    Reg. 34 (1) Annual Report.
    Annual Report for FY26

Frequently Asked Questions

Where can I download the annual report of Windlas Biotech Ltd.?
Annual reports of Windlas Biotech Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Windlas Biotech Ltd.?
Quarterly earnings results and presentations of Windlas Biotech Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Windlas Biotech Ltd. publish earnings call transcripts?
Earnings call transcripts of Windlas Biotech Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Windlas Biotech Ltd.?
Investor presentations and annual day presentations of Windlas Biotech Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Windlas Biotech Ltd.?
Corporate announcements and regulatory filings of Windlas Biotech Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Windlas Biotech Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Windlas Biotech Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Windlas Biotech Ltd.?
The ISIN (International Securities Identification Number) of Windlas Biotech Ltd. is INE0H5O01029. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Windlas Biotech Ltd. listed?
Windlas Biotech Ltd. is listed on NSE and BSE. The NSE symbol is WINDLAS and the BSE code is -.
Where can I find the shareholding pattern of Windlas Biotech Ltd.?
The quarterly shareholding pattern of Windlas Biotech Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Windlas Biotech Ltd. on Sharpely?
Share price data for Windlas Biotech Ltd. is updated as of 23 Oct 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.